SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $120,000 | -98.9% | 10,000 | -98.8% | 0.00% | -98.7% |
| Q1 2021 | $10,756,000 | +6794.9% | 858,429 | +8484.3% | 0.24% | +5825.0% |
| Q4 2020 | $156,000 | +66.0% | 10,000 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $94,000 | +4.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $90,000 | +40.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $64,000 | -23.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $84,000 | -7.7% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q3 2019 | $91,000 | -15.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $108,000 | +13.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $95,000 | -17.4% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $115,000 | -32.0% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $169,000 | +19.0% | 10,000 | 0.0% | 0.01% | +20.0% |
| Q2 2018 | $142,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
| EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
| FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
| Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
| DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
| RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
| Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
| Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
| WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
| Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |